Press Releases Year All Years 2020 2019 2018 2017 2016 2015 2014 Category All Releases Financial Releases Recro Pharma Appoints Michael Celano as Chief Financial Officer Jul 05, 2016 7:00am EDT Recro Pharma to Present at the Jefferies 2016 Global Healthcare Conference Jun 02, 2016 7:00am EDT Recro Pharma Reports First Quarter 2016 Financial Results May 12, 2016 9:07am EDT Recro Pharma Presents Clinical Data at American Pain Society 35th Annual Scientific Meeting May 12, 2016 9:00am EDT Recro Pharma Reports Year End 2015 Financial Results Mar 24, 2016 8:20am EDT Recro Pharma to Present at the 28th Annual ROTH Conference Mar 07, 2016 8:00am EST Recro Pharma Appoints Fred Graff as Chief Commercial Officer Feb 16, 2016 8:00am EST Recro Pharma Initiates Second Pivotal Phase III Clinical Trial of IV Meloxicam for Acute Postoperative Pain Feb 01, 2016 8:00am EST Recro Pharma Initiates Pivotal Phase III Clinical Trial of IV Meloxicam for Acute Postoperative Pain Jan 27, 2016 8:00am EST Recro Pharma to Present at NobleCon12 Investor Conference Jan 14, 2016 1:19pm EST Prev 1... 7 8 9 10 11 12 13 14 15 16 Next
Recro Pharma Presents Clinical Data at American Pain Society 35th Annual Scientific Meeting May 12, 2016 9:00am EDT
Recro Pharma Initiates Second Pivotal Phase III Clinical Trial of IV Meloxicam for Acute Postoperative Pain Feb 01, 2016 8:00am EST
Recro Pharma Initiates Pivotal Phase III Clinical Trial of IV Meloxicam for Acute Postoperative Pain Jan 27, 2016 8:00am EST
